Akaoka H, Roussel B, Lin J, Chouvet G, Jouvet M (1991) Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity. Neurosci Lett 123:20–22
Baker LE, Riddle EE, Saunders RB, Appel JB (1993) The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol 4:69–79
Balster RL (1991) Drug abuse potential evaluation in animals. Br J Addict 86:1549–1558
Balster RL, Schuster CR (1973) A comparison ofd-amphetamine,l-amphetamine and methamphetamine self-administration in rhesus monkeys. Pharmacol Biochem Behav 1:67–71
Balster RL, Woolverton WL (1982) Intravenous buspirone self-administration in rhesus monkeys. J Clin Psychiatry 43:34–37
Balster RL, Carroll FI, Graham JH, Mansbach RS, Rahman A, Lewin AH, Showalter VM (1991) Potent substituted-β-phenyltropane analogs of cocaine have cocaine-like discriminative stimulus effects. Drug Alcohol Depend 29:145–151
Bastuji H, Jouvet M (1988) Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsychopharmacol Biol Psychiatry 12:695–700
Beardsley PM, Balster RL, Harris LS (1986) Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug Alcohol Depend 18:149–157
Boivin DB, Montplaisir J, Petit D, Lambert C, Lubin S (1993) Effects of modafinil on symptomatology of human narcolepsy. Clin Neuropharmacol 16:46–53
Bruno A, Nolte KB, Chapin J (1993) Stroke associated with ephedrine use. Neurology 43:1313–1316
Carney JM, Uwaydah IM, Balster RL (1977) Evaluation of a suspension system for intravenous self-administration studies of water-insoluble compounds in the rhesus monkey. Pharmacol Biochem Behav 7:357–364
Chait LD (1994) Factors influencing the reinforcing and subjective effects of ephedrine in humans. Psychopharmacology 113:381–387
Deneau G, Yanagita T, Seevers MH (1969) Self-administration of psychoactive substances by the monkey. Psychopharmacology 16:30–43
Duteil J, Rambert FA, Pessonnier J, Hermant J, Gombert R, Assous E (1990) Central α1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur J Pharmacol 180:49–58
Fishman MW, Schuster CR, Resnekov L, Shick JFE, Krasnegor NA, Fennell W, Freedman DX (1976) Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch Gen Psychiatry 33:983–989
Fuxe K, Janson AM, Rosen L, Finnman U-B, Tanganelli S, Morari M, Goldstein M, Agnati LF (1992) Evidence for protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis. Exp Brain Res 88:117–130
Gauvin DV, Harland RD, Michaelis RC, Holloway FA (1989) Caffeine-phenylethylamine combinations mimic the cocaine discriminative cue. Life Sci 44:67–73
Gauvin DV, Moore KR, Youngblood BD, Holloway FA (1993) The discriminative stimulus properties of legal, over-the-counter stimulants administered singly and in binary and ternary combinations. Psychopharmacology 110:309–319
Hermant J-F, Rambert FA, Duteil J (1991) Awakening properties of modafinil: effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated administration. Psychopharmacology 103:28–32
Holtzman SG (1990) Discriminative stimulus effects of drugs: relationship to abuse liability. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse. Modern methods in pharmacology, vol. 6. Wiley-Liss, New York, pp. 193–210
Huang J, Ho BT (1974) Discriminative stimulus properties ofd-amphetamine and related compounds in rats. Pharmacol Biochem Behav 2:669–673
Johanson CE, Balster RL (1978) A summary of the results of a drug self-administration study using substitution procedures in rhesus monkey. Bull Narc 30:43–54
Kamien JB, Woolverton WL (1989) A pharmacological analysis of the discriminative stimulus properties ofd-amphetamine in rhesus monkeys. J Pharmacol Exp Ther 248:938–946
Lagarde D, Milhaud C (1990) Electroencephalographic effects of modafinil, an alpha-1-adrenergic psychostimulant, on the sleep of rhesus monkeys. Sleep 13:441–448
Lamb RJ, Griffiths RR (1990) Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine. Psychopharmacology 102:183–190
Lin JS, Roussel B, Akaoka H, Fort P, Debilly G, Jouvet M (1992) Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 591:319–326
Mansbach RS, Balster RL (1993) Effects of mazindol on behaviors maintained or occasioned by cocaine. Drug Alcohol Depend 31:183–191
Mansbach RS, Sannerud CA, Griffiths RR, Balster RL, Harris LS (1990) Intravenous self-administration of 4-methylaminorex in primates. Drug Alcohol Depend 26:137–144
Martin WR, Sloan MD, Sapira JD, Jasinski DR (1971) Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245–258
Mignot E, Nishino S, Guilleminault C, Dement WC (1994) Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 17:436–437
Pigeau R, Natioh P, Buguet A, McCann C, Baranski J, Taylor M, Thompson M, Mack I (1995) Modafinil,d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res 4:212–218
Rambert FA, Pessonnier J, Duteil J (1990) Modafinil, amphetamine and methylphenidate-induced hyperactivities in mice involve different mechanisms. Eur J Pharmacol 183:455–456
Simon P, Panissaud C, Costentin J (1994) The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. Psychopharmacology 114:597–600
Snoddy AM, Tessel RE (1983) Nisoxetine and amphetamine share discriminative stimulus properties in mice. Pharmacol Biochem Behav 19:205–210
Terry P, Witkin JM, Katz JL (1994) Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J Pharmacol Exp Ther 270:1041–1048
Touret M, Sallanon-Moulin M, Jouvet M (1995) Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat. Neurosci Lett 189:43–46
Ueki A, Rosen L, Agnati LF, Hallstrom A, Goiny M, Tanganelli S, Ungerstedt U, Fuxe K (1993a) Evidence for a preventive action of the vigilance-promoting drug modafinil against striatal ischemic injury induced by endothelin-1 in the rat. Exp Brain Res 96:89–99
Ueki A, Rosen L, Andbjer B, Finnman U-B, Altamimi U, Janson AM, Goldstein M, Agnati LF, Fuxe K (1993b) The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway. Exp Brain Res 93:259–270
Woodward JJ, Mansbach RS, Carroll FI, Balster RL (1991) Cocaethylene inhibits dopamine uptake and produces cocaine-like actions in drug discrimination studies. Eur J Pharmacol 197:235–236
Woolverton WL (1991) Discriminative stimulus effects of cocaine. In: Glennon RA, Jarbe TUC, Frankenheim J (eds) Drug discrimination: applications to drug abuse research. NIDA Research Monograph Series 116, DHHS Publication number (ADM)92-1878, pp 61–74
Woolverton WL, Nader MA (1990) Experimental evaluation of the reinforcing effects of drugs. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse. Modern methods in pharmacology, vol. 6. Wiley-Liss, New York, pp 165–192
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4